These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9487314)

  • 41. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
    MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
    [No Abstract]   [Full Text] [Related]  

  • 43. [Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer].
    Butorov IV; Osoianu IuP; Maksimov VV; Butorov SI
    Klin Med (Mosk); 2006; 84(1):53-6. PubMed ID: 16512399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
    Namiot DB; Namiot Z; Kemona A; Bucki R; Gotebiewska M
    Helicobacter; 2007 Feb; 12(1):63-7. PubMed ID: 17241303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical effectiveness and cost-effectiveness of Helicobacter pylori testing and treatment in patients receiving long-term ulcer prophylaxis.
    Skog JH; Morreale AP; Plowman BK; Rapier R; Dole S
    Am J Health Syst Pharm; 2004 Mar; 61(6):608-12. PubMed ID: 15061433
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapy of Helicobacter pylori infection].
    Treiber G
    Praxis (Bern 1994); 2000 May; 89(22):958-62. PubMed ID: 10893994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New treatments for peptic ulcer disease.
    Cornell S
    Adv Nurse Pract; 1997 Mar; 5(3):57-9. PubMed ID: 9459883
    [No Abstract]   [Full Text] [Related]  

  • 48. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quadruple treatments for Helicobacter pylori.
    Mascitelli L; Pezzetta F
    Lancet; 2003 Jan; 361(9351):86. PubMed ID: 12517510
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacoeconomics in the therapy of peptic ulcer].
    Tesar T; Foltán V; Huorka M
    Ceska Slov Farm; 2002 Mar; 51(2):78-83. PubMed ID: 11928281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peptic ulcer disease etiology, diagnosis and treatment].
    Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
    Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Is a 1-week treatment enough and safe for the healing of peptic ulcer?].
    Pajares JM; Gisbert JP
    Rev Esp Enferm Dig; 2000 Jan; 92(1):1-4. PubMed ID: 10758728
    [No Abstract]   [Full Text] [Related]  

  • 54. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
    Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
    Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ulcer therapy update.
    Brozenec SA
    RN; 1996 Sep; 59(9):48-50; 52-3; quiz 54. PubMed ID: 8868747
    [No Abstract]   [Full Text] [Related]  

  • 58. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.
    Tseng GY; Lin HJ; Fang CT; Yang HB; Tseng GC; Wang PC; Hung TL; Deng YC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2007 Sep; 26(6):925-33. PubMed ID: 17767477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
    Zullo A; Cristofari F; Hassan C
    Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053
    [No Abstract]   [Full Text] [Related]  

  • 60. H. pylori eradication therapy.
    McLaughlin RP
    Ala Med; 1996; 65(8-10):20-2. PubMed ID: 8871512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.